Clinical Research Directory
Browse clinical research sites, groups, and studies.
Recommendations for the Treatment of Children With Acute Lymphoblastic Leukemia in the GFAOP
Sponsor: French Africa Pediatric Oncology Group
Summary
The LALGFA2019 Recommendations redefine the standard risk criteria and propose to introduce anthracycline induction in so-called high-risk forms (LAL line T and LAL line B with leukocytosis greater than or equal to 50 G/L or in children less than 1 year of age or more than 10 years of age) as well as Endoxan and Methotrexate in high dose consolidation.
Key Details
Gender
All
Age Range
Any - 18 Years
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2021-11-15
Completion Date
2030-12-31
Last Updated
2026-03-02
Healthy Volunteers
Not specified
Conditions
Locations (3)
CHU de Treichville à ABIDJAN
Abidjan, Côte d’Ivoire
CHU Donka 030 BP 554
Conakry, Guinea
Hôpital Aristide Le Dantec, Avenue Pasteur,
Dakar, Senegal